Kristopher Sturgis is a freelance contributor to MD+DI.
Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.
An industry expert shares a few tips on how to be proactive when it comes to evaluating and improving product performance.
An expert in quality management discusses the importance of a quality design plan and how to map out a path to success for device makers.
BAROnova has submitted a premarket approval application to FDA for an implantable device designed to treat obesity.
A new diagnostic system with digital imaging capabilities aims to enhance lab capabilities across the globe through multi-test processing, dry slide technology, and a full testing environment for accurate testing in a waterless environment.
The new implant was specifically designed to simplify key stages of spinal fusion surgery to help restore spinal disc height between two vertebrae.
FibreTuff plans to develop cellulose-based biomaterials that can be used to 3D print Class I and II medical devices for spine, trauma, and sports medicine.
Doctors from AmCad BioMed Corp have developed a new screening and imaging tool specifically designed to improve the early detection of thyroid cancer with advanced ultrasound technology.
The two technology groups will collaborate to expand SCHOTT’s hermetic packaging portfolio with an innovative new glass micro bonding technology that will create new possibilities for electronic implantable devices.
Physicians from Taiwan unveil new glasses that would allow surgeons to visualize a 3-D model of a patient’s anatomy in real time.
New research out of Bentley University aims to explore the genetic links between human DNA and opioid addiction. The new study could help doctors identify patients susceptible to opioid dependence and choose different treatment methods.
ivWatch monitoring devices will now be compatible with Philips Intellivue Patient Monitors, enabling more healthcare facilities to use ivWatch devices to monitor peripheral IVs for infiltration and extravasation events.
The company’s chemically reactive coating could ensure a contaminant-free environment for nitric oxide tubing, a lifesaving drug used to treat oxygen-deprived newborns.
NeuroPace launches its Next Gen RNS system with brain-computer interface technology to monitor brain waves and send subtle electrical pulses to the brain to prevent seizures.